23. PTC Learning Objectives

23. PTC Learning Objectives

"Has this visit been worth my time?"

 Universal Learning Objectives

knowledge is power
  1. Understand and acknowledge the increased risk of cancer post-transplant, and the risk breakdown for their specific organ type.
    1. The reason why you are at risk.
    2. The specific cancers that you are at higher risk for
      1. This is how high the risk is.
    3. What should I be doing at home to be a responsible patient?
    4. Key things to look for and when to talk to a doctor.
    5. What actions to take if these symptoms appear.
  2. Create a personal action plan for cancer prevention steps and routine screening.
  3. Learn to recognize the symptoms of common post-transplant cancers.
  4. Learn how to do a self-examination and know how often to do it.
  5. Commit to regular post-transplant cancer screenings. Know and plan for how often screenings are needed.
  6. Acknowledge the importance of seeing practitioners who are experienced working with post-transplant patients who can effectively manage cancer risk with the patient.

    computer 3343887 1280

Specific Learning Objectives

This post-transplant cancer educational resource has several measurable goals for the viewer. Look carefully at the following list and see if you have met those objectives . . .
Note: In each objective listed below, they are meant to be 'measurable objectives' - we plan to add self-testing resources for each to provide that measurement of success in a future update - stay tuned.

Objective #1: organ recipients will understand and acknowledge their increased risk over time of cancer post-transplant. Specifically understanding which cancers present a higher risk based on their organ transplant type.
     How will this be measured?
          • Via multiple-choice survey question contrasting non-transplant population vs. transplant population

Objective #2: organ recipients will learn and apply PTC best practices using a written set of goals personalized from these best practices designed to prevent and diagnose common types of post-transplant cancers.
     How will this be measured?
          • By quiz based on best practice actions. By solicitation/reminder of goal statements.

Objective #3: organ recipients will learn to recognize symptoms of common post-transplant cancers
     How will this be measured?
          • By a matching exercise between names of cancer and common symptoms. For example,
            pictures of skin cancers, as one example – see: https://www.aad.org/public/spot-skin-cancer/learn-about-skin-cancer/spot-skin-cancer-quiz)

Objective #4: organ recipients will carefully, regularly self-examine/self-assess symptoms for signs of cancer, proactively following up on any suspicious symptoms with their medical teams.
     How will this be measured?
          • By survey quiz showing examples of self-exams/self-assessment recommendations (for non-visible cancers).
            Periodic reminder surveys that call for confirming responses when action is taken.

Objective #5: organ recipients will take actions to engage medical professionals in periodic screenings for post-transplant cancers appropriate to their type of transplant, age, length of time from transplant and personal/family history of cancer.
     How will this be measured?
          • By periodic reminder surveys that call for confirming responses when action is taken.

Objective #6: organ recipients will ensure that exams and diagnosis concerns are not dismissed in being overly simplified, rather handled by organ transplant specialists familiar with the higher risk of cancer for transplant recipients.
     How will this be measured?
          • Using recipient/doctor scenarios to select appropriate levels of concern/treatment from stories
            demonstrating suitable and unsuitable treatment of concerns.

 

*****************************************************************************************************************************************************

InteractiveLearnngTool

The following interactive learning tool is intended to assess understanding and reinforce learning.  While your results are anonymous, the combined scoring is collected as a means of identifying weaknesses in content presentation for future updates to support learning improvement.  Please enjoy this tool as a
fun and learning experience!

Choose a resource for more information:

Sponsors & Supporters


  • Gift of Life Donor Program
    Platinum
  • CareDx
    Platinum
  • Atara Bio
    Bronze
  • GuideStar 2020 Platinum
  • UNOS
    Sponsor
  • AAKP
    Bronze
  • Clinical Consulting Associates
    Bronze
  • GLI
    Supporter
  • Notion design sponsor
    Supporter
  • solicitation
    various
    Follow TRIO on  
    17560 Buckingham Garden Drive Lithia, FL 33547 1-813-800- TRIO (8746) • info@trioweb.org
    EIN# 251569468

    DISCLAIMER: The content of this TRIO post-transplant cancer Web site is not influenced by sponsors. The site is designed primarily for use by transplant recipients and their supporters. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with your transplant team or a physician skilled in cancer and your organ type if you suspect you are ill.